This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hodgkin lymphoma, hilmo
CD2_HODGKIN_LYMPHOMA
non-Hodgkins lymphoma: Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1069 |
4. Check minimum number of eventsNone |
1069 |
5. Include endpointsNone |
1069 |
6. Filter based on genotype QC (FinnGen only) |
1069 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C81-C96
- Name in latin
- Morbus Hodgkin
Similar endpoints
↥List of similar endpoints to
Hodgkin lymphoma, hilmo
based on the number of shared cases.
Similar with more cases:
- Hodgkin lymphoma
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1069 | 507 | 562 |
| Unadjusted period prevalence (%) | 0.21 | 0.17 | 0.25 |
| Median age at first event (years) | 44.62 | 36.88 | 51.60 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 949
- Matched controls
- 9487
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
199.8
323.0
694
127
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
323.0
481
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
323.0
371
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
116.8
254.7
269
32
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
33.9
246.7
329
146
A03FA01
ATC
metoclopramide; systemic, rectal
11.9
241.8
559
1023
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
44.7
238.8
296
95
L03AA02
ATC
filgrastim; parenteral
54.9
215.0
255
63
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
204.8
189
*
JN4BD
NOMESCO Finland
Extensive body CT
13.8
203.0
390
457
PJA10
NOMESCO Finland
Exploration of lymph nodes
75.8
159.1
179
29
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
54.3
152.2
181
41
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
150.1
140
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
145.7
136
*
M04AA01
ATC
allopurinol; systemic
8.7
137.9
342
580
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
+∞
135.8
127
*
XW000
NOMESCO Finland
Bone marrow biopsy
19.4
133.9
211
138
H02AB02
ATC
dexamethasone; systemic
10.3
129.1
280
372
A04AA01
ATC
ondansetron; systemic, rectal
11.0
108.4
221
254
A04AA02
ATC
granisetron; systemic, transdermal
11.7
102.6
202
215
L03AA13
ATC
pegfilgrastim; parenteral
17.3
91.1
148
100
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
+∞
89.0
84
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
70.2
83.3
95
15
JN4AD
NOMESCO Finland
Body CT examination
8.2
79.8
192
284
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
54.1
78.3
93
19
EP1AE
NOMESCO Finland
Neck ultrasound examination
9.7
76.5
164
199
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
76.1
552
2633
JN6AD
NOMESCO Finland
CT of torso and neck
38.5
73.9
94
27
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.3
72.4
172
247
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
42.3
68.3
85
22
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
25.0
68.3
97
43
R50.9
ICD-10 Finland
Fever, unspecified
4.6
66.9
270
751
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
86.6
65.0
72
9
D70.82
ICD-10 Finland
Drug-induced neutropenia
22.0
62.3
92
46
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
217.0
59.8
61
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
23.0
59.1
86
41
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
30.6
59.0
79
28
WW500
NOMESCO Finland
Blood transfusion
10.3
59.0
121
133
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.2
58.3
201
465
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
580.9
56.2
55
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
43.7
55.9
69
17
A04AA55
ATC
palonosetron, combinations; systemic
16.1
55.2
91
62
ZX120
NOMESCO Finland
Intravenous
5.1
53.7
188
440
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
53.1
447
2172
XX9CD
NOMESCO Finland
Very extensive complementary CT
280.9
52.7
53
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
52.6
50
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
25.4
51.9
73
31
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
8.6
51.4
117
153
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
524.8
50.9
50
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
31.2
50.4
67
23
A04AD12
ATC
aprepitant; systemic
17.2
48.7
78
49
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
13.6
47.6
84
67
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
131.8
47.2
50
*
J01MA12
ATC
levofloxacin; systemic
3.4
45.9
263
952
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
11.6
45.1
86
81
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
30.4
44.9
60
21
C83.1
ICD-10 Finland
Mantle cell lymphoma
75.1
44.4
50
7
WF003
NOMESCO Finland
Adjuvant radiotherapy
9.4
44.0
94
110
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
18.2
43.5
68
40
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
7.1
41.1
105
163
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
36.6
40.8
52
15
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.6
40.7
91
115
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
16.5
40.2
65
42
20199
ICD-8 Finland
Hodgkin's disease
146.3
40.1
42
*
A02BC02
ATC
pantoprazole; systemic
2.5
39.6
645
4318
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
39.4
295
1268
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
25.9
38.8
54
22
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
37.6
204
696
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.2
37.6
106
188
C81
ICD-10 Finland
Hodgkin lymphoma
+∞
36.7
35
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.5
36.5
82
104
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.2
36.1
118
250
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
+∞
35.6
34
*
WF002
NOMESCO Finland
Radical radiotherapy
5.7
35.2
106
204
1XC02
NOMESCO Finland
NA
26.5
34.8
48
19
H02AB06
ATC
prednisolone; systemic
2.4
34.8
490
2952
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
14.6
34.8
59
43
9659/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph node, NOS
+∞
34.6
33
*
9659/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of multiple regions
+∞
34.6
33
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
34.3
210
777
J05AB11
ATC
valaciclovir; oral
3.5
34.3
182
607
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
32.5
31
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
33.7
32.4
42
13
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
31.7
253
1109
TGC00
NOMESCO Finland
Bronchial lavation
9.0
31.4
68
81
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
+∞
31.4
30
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
29.2
31.3
42
15
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.9
31.1
139
400
H02AB07
ATC
prednisone; oral
3.2
31.0
181
645
L03AA14
ATC
lipegfilgrastim; parenteral
14.8
31.0
52
37
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.7
29.9
144
441
H03AA01
ATC
levothyroxine sodium; systemic
2.7
29.7
251
1133
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
68.2
29.1
33
5
ZXE00
NOMESCO Finland
One hour or less
2.2
28.0
425
2560
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
27.9
308
1598
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
26.4
237
1096
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
37.9
26.3
33
9
Z31.6
ICD-10 Finland
General counselling and advice on procreation
12.7
25.7
46
38
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
17.3
25.5
40
24
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
14.0
25.2
43
32
9652/3-C77.8
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of multiple regions
+∞
25.1
24
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.6
25.0
75
143
4701
FHL
Neck lymph node removal
40.0
25.0
31
8
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
16.0
24.8
40
26
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.8
24.7
111
319
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
24.4
132
440
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.4
24.3
91
221
9652/3-C77.0
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of head, face and neck
+∞
24.1
23
*
9650/3-C77.9
ICD-O-3
Hodgkin lymphoma, NOS, of lymph node, NOS
+∞
24.1
23
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
69.3
23.9
27
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
23.9
198
869
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.7
23.2
82
188
9650/3-C77.1
ICD-O-3
Hodgkin lymphoma, NOS, of intrathoracic lymph nodes
235.4
22.7
23
*
N02AA05
ATC
oxycodone; systemic
2.8
22.3
162
657
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.1
22.3
62
108
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
22.0
364
2211
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
18.0
21.4
33
19
WZC30
NOMESCO Finland
Teaching
2.7
21.3
156
635
ZX112
NOMESCO Finland
Subcutaneous
8.1
21.2
48
62
GEA00
NOMESCO Finland
Mediastinoscopy
34.7
21.2
27
8
B01AB05
ATC
enoxaparin; parenteral
2.1
21.1
296
1671
9663/3-C77.1
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of intrathoracic lymph nodes
+∞
20.9
20
*
2014A
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,""""LYMPHOCYTIC PREDOMINANCE"""",""""NODULAR""""]
+∞
20.9
20
*
2016A
ICD-9 Finland
Hodgkin's disease, Mixed cellularity
+∞
20.9
20
*
A41.9
ICD-10 Finland
Sepsis, unspecified
5.2
20.8
66
135
B72
ICPC
Hodgkin Lymphoma
214.5
20.7
21
*
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
11.6
20.6
38
34
ZX090
NOMESCO Finland
Other technic of radiotherapy
7.5
20.2
48
67
104
Kela drug reimbursment
Thyroid insufficiency
3.8
20.2
89
251
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
36.6
19.9
25
7
ZX070
NOMESCO Finland
Intensity modified radiotherapy
7.4
19.8
47
66
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
19.7
99
311
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
12.5
19.7
35
29
WW402
NOMESCO Finland
Leucoferesis
107.3
19.6
21
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
19.2
119
434
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
18.7
19.2
29
16
9659/3-C77.3
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of axilla or arm
+∞
18.8
18
*
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
71.4
18.8
21
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
193.7
18.6
19
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
67.9
17.8
20
*
2015A
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, CELLULAR PHASE]
+∞
17.8
17
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
96.9
17.6
19
*
C03CA01
ATC
furosemide; systemic
2.1
17.6
240
1324
212
Kela drug reimbursment
Gout
8.1
17.4
39
50
ZX108
NOMESCO Finland
Inhalation
12.3
17.4
31
26
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.7
17.3
40
54
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
32.1
17.1
22
7
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
51.0
17.0
20
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.7
16.7
75
216
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
172.9
16.5
17
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.6
16.3
126
523
C83.00
ICD-10 Finland
Lymphocytic lymphoma
30.6
16.2
21
7
WX402
NOMESCO Finland
General anaesthesia
2.2
16.0
178
892
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
34.0
15.8
20
6
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
10.0
15.8
31
32
WX110
NOMESCO Finland
Local anesthesy
1.8
15.7
663
5330
9663/3-C38.3
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of mediastinum, NOS
+∞
15.7
15
*
J01MA14
ATC
moxifloxacin; systemic
2.8
15.1
100
381
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
57.6
14.8
17
*
TPX15
NOMESCO Finland
Removal of vascular injection port
16.8
14.8
23
14
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
14.3
203
1127
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
27.6
14.3
19
7
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.4
14.2
42
80
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
12.2
14.1
25
21
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.9
14.1
46
98
I35.0
ICD-10 Finland
Aortic (valve) stenosis
3.6
13.9
64
188
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
30.5
13.9
18
6
WW409
NOMESCO Finland
Other aferesis
54.2
13.8
16
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
54.2
13.8
16
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
54.2
13.8
16
*
A07AA02
ATC
nystatin; oral
3.2
13.8
73
239
YNB10
NOMESCO Finland
Collection of stem cells for transplant
24.2
13.8
19
8
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
13.8
345
2330
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
13.8
64
190
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
13.6
258
1590
9651/3-C77.9
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph node, NOS
+∞
13.6
13
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.2
13.4
32
46
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
8.3
13.4
29
36
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.8
13.4
44
95
D70.89
ICD-10 Finland
Neutropenic splenomegaly
9.2
13.3
27
30
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
5.6
13.3
38
70
JN4CD
NOMESCO Finland
Very extensive body CT
4.0
13.2
53
139
L01AA02
ATC
chlorambucil; oral
40.7
13.2
16
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
5.2
13.2
40
79
GD1AD
NOMESCO Finland
Thorax CT examination
3.6
13.0
60
177
HA1AA
NOMESCO Finland
X-ray mammography
3.1
13.0
71
239
Z51.5
ICD-10 Finland
Palliative care
3.4
12.9
62
189
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
12.9
277
1776
J01DB01
ATC
cefalexin; oral
1.8
12.8
758
6519
B02.9
ICD-10 Finland
Zoster without complication
3.3
12.8
64
202
N02BE01
ATC
paracetamol; systemic, rectal
1.8
12.7
769
6647
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
12.5
12.6
22
18
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
9.5
12.5
25
27
9651/3-C77.0
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of head, face and neck
+∞
12.5
12
*
9659/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of head, face and neck
+∞
12.5
12
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
12.5
12
*
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
5.2
12.2
37
73
1AA09
NOMESCO Finland
NA
47.3
11.9
14
*
Z2446
NOMESCO Finland
Social worker
2.8
11.8
80
306
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
11.6
93
396
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
11.5
11
*
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
+∞
11.5
11
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
11.5
11
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
121.4
11.4
12
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
11.4
484
3728
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.2
11.3
34
67
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
11.3
11.1
20
18
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
14.1
11.0
18
13
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.7
10.8
30
54
ZXA05
NOMESCO Finland
Left side
1.8
10.7
212
1311
R06.0
ICD-10 Finland
Dyspnoea
1.8
10.6
211
1307
Z3231
NOMESCO Finland
Registered nurse
1.7
10.5
249
1629
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
4.6
10.4
35
78
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
111.2
10.4
11
*
WW200
NOMESCO Finland
Immunization
4.0
10.4
41
107
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
10.3
107
514
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
9.7
10.3
20
21
ZXD05
NOMESCO Finland
Urgent procedure
1.7
10.3
284
1939
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
10.1
382
2824
WX002
NOMESCO Finland
Sedation and analgesia
1.9
10.0
173
1019
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
40.5
10.0
12
*
J05AB01
ATC
aciclovir; systemic
1.8
9.9
182
1094
ZXA00
NOMESCO Finland
Right side
1.7
9.8
218
1395
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
55.6
9.7
11
*
JAH00
NOMESCO Finland
Laparotomy
4.5
9.6
33
76
A04AA03
ATC
tropisetron; systemic
15.2
9.5
15
10
TGD00
NOMESCO Finland
Needle biopsy of lung
15.2
9.5
15
10
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
101.0
9.4
10
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
5.7
9.4
26
47
1XC12
NOMESCO Finland
NA
+∞
9.4
9
*
JAH20
NOMESCO Finland
Staging laparotomy
+∞
9.4
9
*
9650/3-C77.8
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of multiple regions
+∞
9.4
9
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
21.9
9.4
13
6
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
21.9
9.4
13
6
121
Kela drug reimbursment
Severe hypofunction of sexual glands
4.7
9.1
30
66
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.7
9.1
30
66
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.7
9.1
39
110
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
9.1
99
488
120
Kela drug reimbursment
Hypogammaglobulinaemia
37.1
9.0
11
*
R4110
NOMESCO Finland
Physiotherapy
1.7
9.0
218
1428
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.4
8.9
31
73
6753
FHL
Transabdominal splenectomy
50.5
8.7
10
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.8
8.6
35
95
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
11.7
8.6
15
13
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
8.6
68
288
D69.5
ICD-10 Finland
Secondary thrombocytopenia
16.5
8.6
13
8
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.9
8.5
50
178
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.2
8.5
25
49
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
90.8
8.4
9
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
8.4
87
420
9651/3-C77.8
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of multiple regions
+∞
8.3
8
*
127
Kela drug reimbursment
Transplant complication
5.0
8.2
25
51
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.6
8.2
59
237
SPAT1255
SPAT
Intravenous administration of medicine
2.5
8.1
62
257
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
8.1
92
462
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
33.6
8.1
10
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
33.6
8.1
10
*
5702
FHL
Local lymph node removal (eg armpit, groin)
17.3
8.1
12
7
A02BC01
ATC
omeprazole; systemic
1.6
8.1
225
1526
FM1FN
NOMESCO Finland
Heart function isotope examination
22.2
8.0
11
5
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
22.2
8.0
11
5
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
8.5
7.8
16
19
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
4.9
7.8
24
50
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
9.5
7.8
15
16
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
9.5
7.8
15
16
R05
ICD-10 Finland
Cough
1.7
7.7
160
994
H02AB09
ATC
hydrocortisone; systemic
3.6
7.6
33
95
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
8.1
7.6
16
20
Z51.0
ICD-10 Finland
Radiotherapy session
6.8
7.6
18
27
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
25.2
7.6
10
*
EMA10
NOMESCO Finland
Biopsy of tonsil
25.2
7.6
10
*
Z2221
NOMESCO Finland
Medical doctor
1.6
7.6
236
1644
JMA10
NOMESCO Finland
Transabdominal total splenectomy
8.9
7.6
15
17
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.8
7.5
47
174
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
7.4
71
332
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
7.4
136
815
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.4
7.4
60
257
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.7
7.4
48
184
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
8.4
7.3
15
18
2014X
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,LYMPHOCYTIC PREDOMINANCE"""",NUD]
+∞
7.3
7
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
7.3
7
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
+∞
7.3
7
*
2017X
ICD-9 Finland
Hodgkin's disease, Lymphocytic depletion[MORBUS HODGKIN, LYMPHOCYTIC DEPLETION NUD]
+∞
7.3
7
*
9659/3-C77.4
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of inguinal region or leg
+∞
7.3
7
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
7.3
77
374
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
5.5
7.2
20
37
ZX121
NOMESCO Finland
Central venous catheter
15.9
7.2
11
7
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
20.2
7.1
10
5
JAH01
NOMESCO Finland
Laparoscopy
2.7
7.1
46
175
L04.9
ICD-10 Finland
Acute lymphadenitis, unspecified
12.1
7.1
12
10
R06AE07
ATC
cetirizine; oral
1.5
7.1
375
2929
R50.8
ICD-10 Finland
Other specified fever
10.1
7.0
13
13
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.7
6.9
22
48
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
7.6
6.9
15
20
L01BB05
ATC
fludarabine; systemic
13.9
6.9
11
8
ZX080
NOMESCO Finland
Image guided radiotherapy
4.2
6.8
24
58
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
6.8
6.8
16
24
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
40.3
6.8
8
*
WX892
NOMESCO Finland
Monitored bed care
2.2
6.7
69
332
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
6.7
72
355
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
22.7
6.7
9
*
UJF32
NOMESCO Finland
Coloscopy
1.6
6.7
190
1290
A06AD11
ATC
lactulose; oral
1.8
6.7
112
654
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.8
6.6
20
42
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
6.5
72
357
Z10.8
ICD-10 Finland
Routine general health check-up of other defined subpopulations
2.4
6.5
53
231
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
70.3
6.4
7
*
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
70.3
6.4
7
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
6.4
148
948
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.4
6.4
29
88
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.2
6.3
22
53
A79
ICPC
Malignancy NOS
6.0
6.3
16
27
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
5.6
6.3
17
31
N05BA06
ATC
lorazepam; systemic, sublingual
2.5
6.3
45
183
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
18.1
6.3
9
5
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
18.1
6.3
9
5
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
18.1
6.3
9
5
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
+∞
6.3
6
*
L01XB01
ATC
procarbazine; oral
+∞
6.3
6
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
6.3
6
*
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
+∞
6.3
6
*
PJ023
NOMESCO Finland
Adjuvant radiotherapy of mediastinal lymphnodes
+∞
6.3
6
*
B59
ICD-10 Finland
Pneumocystosis
26.9
6.2
8
*
4704
FHL
Neck tumor removal
26.9
6.2
8
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
6.2
90
499
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.8
6.1
37
137
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
6.1
71
360
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
6.1
63
307
TK800
NOMESCO Finland
Hemodialysis
3.4
6.1
27
81
RS221
NOMESCO Finland
NA
4.4
6.1
20
46
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
8.7
6.1
12
14
6BA02
NOMESCO Finland
NA
10.1
6.0
11
11
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.8
6.0
23
61
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
611
882
14.84
307.65
7.1
4.2
u/l
232.2
244.4
1.09
593
838
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
202
51
48.60
307.65
1.4
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
263
67
51.74
307.65
1.5
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
403
780
7.69
216.44
1.5
1.5
—
—
—
0
0
(4035726)
344
688
6.90
175.54
1.8
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
449
1206
5.70
165.67
1.6
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
132
88
16.97
152.83
1.5
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
122
75
18.23
147.08
2.5
2.3
e9/l
1.0
1.2
0.51
93
38
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
105
48
24.15
144.30
2.3
2.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
148
143
11.85
137.15
3.0
3.2
u/ml
824.4
2214.8
0.40
19
13
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
102
54
20.78
131.63
2.3
2.3
%
14.6
14.1
0.08
35
26
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
162
189
9.92
131.07
5.8
5.7
iu/ml
324.0
418.0
0.26
27
25
(3022096) Basophils/100 leukocytes in Blood
793
3883
5.04
127.41
9.7
6.0
%
0.7
0.7
0.85
762
3656
(3006315) Basophils [#/volume] in Blood
837
4275
5.41
127.15
9.8
5.9
e9/l
0.0
0.0
0.18
768
3735
(3001604) Monocytes [#/volume] in Blood
834
4260
5.36
126.34
9.8
5.8
e9/l
0.6
0.6
2.29
765
3714
(3006504) Eosinophils/100 leukocytes in Blood
803
4012
5.02
124.43
9.8
5.9
%
2.8
2.8
0.11
774
3769
(3019069) Monocytes/100 leukocytes in Blood
804
4036
5.00
123.38
10.3
6.2
%
9.2
8.6
5.35
775
3817
(3013115) Eosinophils [#/volume] in Blood
843
4423
5.29
121.05
10.7
6.1
e9/l
0.2
0.2
0.08
778
3917
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
478
1681
4.33
119.36
1.7
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
838
4405
5.18
119.24
9.9
5.8
e9/l
1.8
2.0
0.62
773
3915
(3005719) IgG [Mass/volume] in Serum or Plasma
288
681
5.42
118.97
3.9
2.5
g/l
9.4
10.7
3.83
271
618
(3042111) Morphology [Interpretation] in Bone marrow Narrative
128
124
11.59
118.02
1.4
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
805
4171
4.77
114.97
10.2
6.0
%
25.9
28.2
5.85
774
3924
(3018010) Neutrophils/100 leukocytes in Blood
798
4111
4.71
114.80
9.5
5.8
%
58.1
57.0
1.31
768
3889
(42870588) Differential panel, method unspecified - Blood
644
2859
4.15
114.33
9.3
5.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
102
74
15.13
112.24
2.3
2.1
%
38.8
38.0
—
5
11
(3013650) Neutrophils [#/volume] in Blood by Automated count
872
4936
5.16
106.92
22.1
8.8
e9/l
3.5
4.1
15.00
802
4334
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
64
19
35.77
101.25
2.4
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
526
2168
3.81
101.04
4.2
2.7
umol/l
1681.9
6941.3
3.38
508
1879
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
791
4282
4.26
100.22
14.2
6.3
umol/l
10.5
11.7
0.94
782
4056
(46235355) HIV 1 and 2 tests - Meaningful Use set
503
2091
3.65
93.84
1.9
1.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
65
27
25.57
92.12
2.3
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
62
25
26.27
88.78
1.3
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
671
3437
3.56
88.14
7.8
4.9
g/l
35.0
36.0
4.06
660
3205
(3028026) IgM [Mass/volume] in Serum or Plasma
216
547
4.70
80.02
2.2
1.7
g/l
1.0
1.5
2.46
202
501
(3012095) Magnesium [Moles/volume] in Serum or Plasma
353
1293
3.58
77.76
7.2
3.6
mmol/l
0.8
0.8
0.11
347
1218
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
73
62
12.56
72.78
4.0
3.2
%
39.6
43.2
0.33
19
16
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
105
146
7.87
72.72
2.1
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
123
204
6.68
72.49
2.1
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
272
880
3.80
71.68
4.0
2.8
%
1.7
1.8
0.40
253
796
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
121
200
6.69
71.53
2.1
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
77
73
11.29
71.47
2.9
2.4
e6/l
344.0
773.8
2.98
22
29
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
112
176
6.99
69.42
1.5
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
121
208
6.43
68.77
1.4
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
467
2208
2.98
64.74
8.3
4.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
924
6394
4.28
64.73
17.7
7.4
u/l
81.9
77.4
2.17
906
6022
(3017181) Myelocytes/100 leukocytes in Blood
227
693
3.89
64.57
5.3
4.4
%
1.1
0.8
0.77
128
215
(3021589) Normoblasts [#/volume] in Blood
662
3784
2.97
64.25
16.5
9.1
e9/l
0.0
0.0
0.58
565
3117
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
110
190
6.34
62.09
1.4
1.4
u/ml
105.2
105.4
0.01
22
35
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
128
258
5.50
61.42
2.2
3.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
183
497
4.24
61.05
1.7
2.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
101
163
6.74
60.90
1.6
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
422
1948
2.93
60.26
8.6
4.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
469
2293
2.86
60.08
7.3
4.1
ph
7.4
7.4
0.10
139
413
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
80
101
8.48
59.92
1.7
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
209
639
3.82
58.98
3.9
2.8
e9/l
68.8
71.3
0.50
175
499
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
106
186
6.22
58.83
1.3
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
63
59
11.28
58.83
2.4
2.5
e6/l
488.1
638.3
0.42
52
50
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
668
3951
2.84
58.74
10.1
6.8
mmol/l
1.2
1.2
0.46
543
3379
(3021440) Promyelocytes/100 leukocytes in Blood
212
657
3.78
58.63
5.2
4.5
%
0.2
0.1
1.40
117
198
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
624
3573
2.79
58.30
9.3
6.2
mmol/l
1.2
1.2
1.17
604
3256
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
61
56
11.49
57.71
2.4
2.6
e9/l
0.2
0.2
0.16
52
49
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
82
113
7.78
57.03
1.9
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
335
1407
3.01
56.23
5.2
3.0
mmol/l
2.5
2.4
1.81
323
1230
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
86
135
6.84
53.13
1.7
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
60
61
10.36
52.90
1.5
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
423
2079
2.71
52.03
17.9
6.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
498
2657
2.64
51.80
7.0
3.3
mmol/l
2.4
2.3
0.71
470
2342
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
87
142
6.58
51.76
1.8
1.3
ug/l
2.5
3.1
0.74
80
129
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
69
90
8.13
50.21
2.0
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
71
98
7.69
49.23
1.7
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
872
6225
3.17
49.10
6.7
3.9
mm/h
14.4
11.1
6.34
833
5776
(3002179) Metamyelocytes/100 leukocytes in Blood
191
628
3.49
47.70
5.1
4.3
%
0.9
0.4
1.77
89
158
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
304
1317
2.83
47.10
2.7
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
188
618
3.48
46.93
5.0
4.6
%
0.0
0.6
0.61
93
166
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
75
116
6.88
46.91
1.7
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
181
596
3.45
44.96
2.6
3.1
g/l
65.9
66.7
0.51
173
549
(3042936) Bacteria identified in Isolate by Culture
279
1207
2.77
42.87
2.0
2.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
43
41
10.89
39.52
4.9
2.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
34
22
15.93
39.27
1.2
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
129
375
3.77
38.45
1.8
1.4
iu/l
22.4
20.5
0.24
107
313
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
223
905
2.85
38.29
2.6
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
534
3254
2.28
37.82
11.3
8.5
inr
1.2
1.2
0.01
164
965
(3003458) Phosphate [Moles/volume] in Serum or Plasma
248
1072
2.71
37.66
8.4
6.2
mmol/l
1.0
1.0
0.13
238
997
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
65
114
6.01
35.87
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
218
903
2.78
35.82
2.5
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
59
95
6.51
35.43
2.6
3.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
39
38
10.61
35.28
2.0
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
67
123
5.74
35.26
2.3
2.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
116
335
3.76
34.82
1.7
1.5
u/l
11.8
8.1
1.69
93
274
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
45
9.43
34.06
2.0
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
71
142
5.28
34.04
4.0
3.2
%
1.4
1.3
0.13
62
118
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
46
59
8.10
33.83
2.0
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
38
38
10.33
33.75
2.1
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
91
229
4.25
33.01
1.4
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
108
309
3.78
32.82
2.4
1.9
ug/l
0.6
2.3
1.13
102
274
(3048929) Epstein Barr virus Ab [Presence] in Serum
121
376
3.50
32.49
1.4
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
87
216
4.30
32.11
1.4
1.2
u/ml
254.3
255.8
0.01
50
128
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
66
134
5.18
31.09
1.7
1.5
nmol/l
0.4
0.3
0.23
61
109
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
377
2133
2.19
30.44
3.8
3.0
ng/l
1524.4
1256.7
0.52
339
1807
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
154
580
2.93
29.91
2.4
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
375
2148
2.15
29.09
6.0
4.0
%
88.0
90.4
1.11
369
2104
(3007164) IgA [Mass/volume] in Serum or Plasma
335
1843
2.19
28.74
1.8
1.5
g/l
2.1
2.4
1.17
266
1149
(44790049)
54
98
5.75
28.73
1.7
1.5
—
—
—
0
0
(44790048)
54
98
5.75
28.73
1.7
1.5
—
—
—
0
0
(44806118)
54
98
5.75
28.73
1.7
1.5
—
—
—
0
0
(44790047)
54
98
5.75
28.73
1.7
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
597
4075
2.05
28.69
5.5
4.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
69
162
4.48
27.32
5.1
3.7
%
57.2
56.6
0.13
69
162
(3013826) Glucose [Moles/volume] in Serum or Plasma
677
4895
2.04
27.03
8.2
4.9
mmol/l
6.6
6.6
0.33
654
4548
(3030905) Polymorphonuclear cells [#/volume] in Blood
67
156
4.52
26.80
4.2
3.4
e9/l
3.8
4.4
1.54
67
156
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
105
342
3.30
26.05
1.9
2.1
g/l
1.5
1.4
0.30
87
303
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
50
93
5.59
25.91
2.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
46
81
5.89
25.24
2.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
46
81
5.89
25.24
2.3
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
46
81
5.89
25.24
2.3
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
52
103
5.26
25.16
2.2
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
92
5.53
25.14
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
28
28
10.24
24.79
1.1
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
28
28
10.24
24.79
5.3
2.4
u/l
214.2
194.8
0.32
28
28
(3044640) Blood type and Crossmatch panel - Blood
430
2712
1.98
24.74
4.0
2.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
375
2300
1.97
23.03
3.7
3.1
e6/l
0.7
0.5
0.40
293
1705
(3002032) Base excess in Venous blood by calculation
168
751
2.47
22.96
5.3
4.0
mmol/l
2.0
1.8
0.15
142
603
(3000060) B lymphocytes [#/volume] in Blood
24
22
11.14
22.50
2.3
2.5
e6/l
116.0
226.0
—
10
10
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
28
32
8.96
22.49
3.7
5.7
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
28
32
8.96
22.49
1.9
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
398
2520
1.92
22.03
3.8
3.2
e6/l
23.5
85.6
1.58
317
1919
(3018095) Leukocytes [#/volume] in Urine
449
2971
1.88
21.60
4.3
3.6
e6/l
72.4
92.1
0.21
334
2067
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
80
247
3.42
21.56
1.7
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
482
3277
1.86
21.16
2.6
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
200
999
2.23
21.07
1.6
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
102
372
2.93
20.79
1.9
2.0
u/l
45.2
38.7
1.64
93
329
(3000991) Gas panel - Venous blood
153
686
2.44
20.68
9.9
8.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
62
167
3.88
20.44
6.0
4.4
mmol/l
2.6
2.4
0.21
45
109
(36304419) Bacteria [Presence] in Urine
360
2250
1.90
20.41
3.7
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
172
826
2.29
19.84
4.9
3.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
443
2981
1.83
19.71
3.9
3.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
287
1701
1.94
18.86
2.9
2.5
e6/l
5.7
5.8
0.06
252
1497
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
30
46
6.68
18.82
3.0
3.6
u/ml
4697.1
829.2
1.85
30
46
(40767503) Oxygen content in Capillary blood by calculation
56
149
3.91
18.79
3.3
2.4
%
15.6
16.4
0.39
21
76
(3037756) Immunofixation for Serum or Plasma
58
165
3.66
17.69
1.3
1.8
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
38
78
5.01
17.67
1.9
1.3
e6/l
1500.1
1855.0
0.32
29
52
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
16
11
14.75
17.64
1.0
1.5
—
—
—
0
0
(3010421) pH of Blood
66
205
3.37
17.62
5.9
4.1
ph
7.4
7.4
0.86
59
164
(3012441) Differential panel - Pleural fluid
35
67
5.37
17.58
1.9
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
36
71
5.21
17.50
1.9
1.3
e6/l
18943.2
49357.8
0.73
26
40
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
23
30
7.81
16.60
2.9
2.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
202
1104
2.02
16.54
2.9
2.4
%
20.5
23.8
1.89
184
958
(3036481) Cortisol [Moles/volume] in Serum or Plasma
162
815
2.16
16.52
3.3
2.0
nmol/l
371.6
376.1
0.11
153
755
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
326
2086
1.81
16.49
3.6
2.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
149
735
2.19
15.94
9.7
7.3
mmol/l
9.1
9.2
0.05
142
698
(3026782) Osmolality of Urine
266
1625
1.85
15.52
3.4
2.7
mosm/kgh2o
570.5
571.3
0.02
235
1387
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
431
3035
1.70
15.33
4.8
3.5
ng/l
29.5
38.4
0.84
323
1997
(40768806) Pleura Pathology biopsy report
34
72
4.84
15.26
1.7
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
182
986
2.02
15.18
7.5
3.0
umol/l
9.2
8.8
0.07
165
859
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
922
8048
2.06
14.90
26.2
12.0
ml/min/173m2
88.5
85.9
2.64
822
6558
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
63
212
3.10
14.76
1.7
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
16
15
10.81
14.67
1.6
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
75
281
2.79
14.51
1.7
1.6
—
194.0
—
0
10
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
297
1912
1.77
14.41
1.9
1.8
mg/l
2.0
1.1
1.05
242
1426
(3004789) Transferrin [Mass/volume] in Serum or Plasma
207
1195
1.91
14.29
2.8
2.3
g/l
2.3
2.3
0.77
197
1110
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
43
5.93
14.04
1.2
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
43
5.93
14.04
1.2
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
21
30
7.12
14.02
1.5
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
707
5762
1.67
13.65
4.9
3.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
773
6469
1.70
13.29
5.4
3.8
pmol/l
14.7
14.7
0.27
732
5887
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
79
319
2.59
13.22
2.1
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
38
99
3.94
13.15
1.2
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
16
18
9.01
12.91
1.4
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
17
7
24.63
12.48
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
146
786
1.99
12.27
2.7
2.5
g/l
0.2
0.2
2.93
131
729
(3022948) Iron [Moles/volume] in Serum or Plasma
211
1286
1.80
12.10
2.9
2.4
umol/l
11.8
13.7
2.66
201
1195
(3034860) Kappa light chains.free [Mass/volume] in Serum
62
232
2.78
12.04
2.0
4.0
mg/l
65.9
83.2
0.23
44
191
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
62
232
2.78
12.04
2.0
4.0
mg/l
39.3
44.9
0.15
44
193
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
963
8689
2.09
11.95
32.2
13.3
mg/l
24.4
23.4
0.41
877
6790
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
102
3.72
11.85
4.7
3.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
310
2113
1.66
11.83
2.3
2.1
mg/l
3.3
2.9
1.80
281
1817
(40760888) Immunoglobulin light chains.free panel - Serum
50
168
3.07
11.77
2.1
4.3
—
—
—
0
0
(3002256) Pathology report gross observation
177
1038
1.85
11.47
1.4
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
49
166
3.05
11.38
1.2
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
224
1416
1.74
11.25
3.5
2.7
e6/l
0.9
0.9
0.01
130
800
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
24
49
4.99
11.24
2.9
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
24
49
4.99
11.24
2.9
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
24
49
4.99
11.24
2.9
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
49
4.99
11.24
2.8
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
216
1352
1.75
11.24
3.6
2.9
e6/l
2.4
2.1
0.11
119
740
(3000492) Spirometry study
153
863
1.90
11.18
1.8
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
102
497
2.16
11.17
1.7
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
48
163
3.04
11.11
5.6
3.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
22
42
5.33
11.09
3.0
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
22
42
5.33
11.09
3.0
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
22
7.37
11.00
1.7
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
22
43
5.20
10.82
3.0
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
366
2650
1.58
10.70
1.7
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
30
77
3.98
10.62
1.6
1.3
g/l
0.4
0.3
0.39
21
53
(3028192) IgG subclass 2 [Mass/volume] in Serum
30
77
3.98
10.62
1.6
1.3
g/l
2.3
2.9
0.86
21
53
(3027135) IgG subclass 1 [Mass/volume] in Serum
30
77
3.98
10.62
1.6
1.3
g/l
6.2
6.7
0.27
22
54
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
30
6.09
10.41
1.1
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
355
2592
1.55
9.84
3.1
2.6
u/l
53.3
56.5
0.66
332
2418
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
77
3.84
9.81
1.3
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
955
8705
1.91
9.79
29.8
15.0
mmol/l
139.3
139.6
3.26
939
8475
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
437
3347
1.52
9.67
2.3
2.2
nmol/l
72.5
74.9
1.01
411
3012
(4062490)
29
79
3.75
9.48
1.6
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
104
544
2.01
9.44
1.4
1.3
u/ml
315.4
244.3
0.24
88
502
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
386
2892
1.52
9.41
5.4
3.3
u/l
32.9
33.4
0.07
378
2751
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
36
114
3.23
9.39
5.6
6.2
mg/l
9.0
10.6
1.32
30
101
(3035637) Corticotropin [Mass/volume] in Plasma
32
95
3.44
9.23
1.4
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
954
8728
1.86
9.16
30.3
15.1
mmol/l
4.0
4.0
0.18
937
8482
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
27
6.00
9.14
1.1
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
166
2.79
9.02
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
166
2.79
9.02
1.6
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
64
3.98
8.90
1.2
1.4
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
12
15
8.08
8.87
1.4
1.5
ng/l
102.7
66.7
—
12
9
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
131
759
1.83
8.74
3.0
4.5
ug/l
41.3
26.3
0.31
109
635
(3000093) Morphology [Interpretation] in Blood Narrative
25
65
3.91
8.72
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
39
136
2.94
8.66
1.6
1.5
g/l
0.7
0.8
0.23
31
101
(3031040) Bacteria [#/volume] in Urine by Automated count
656
5532
1.48
8.63
5.0
4.1
e6/l
57.0
1908.4
1.25
14
82
(3008536) Aspergillus sp Ab [Presence] in Serum
14
22
6.43
8.54
4.6
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
30
91
3.36
8.39
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
19
41
4.70
8.37
6.6
7.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
93
489
1.99
8.32
1.5
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
44
168
2.69
8.28
2.9
2.4
g/l
119.6
131.3
1.22
25
119
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
56
241
2.40
8.25
1.3
3.0
g/l
0.2
1.2
2.91
48
220
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
223
1517
1.59
8.21
4.6
3.7
ng/l
310.9
545.3
0.69
174
1123
(40768443) Skin Pathology biopsy report
71
339
2.17
8.21
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
58
255
2.35
8.15
3.3
3.0
u/ml
0.3
0.3
0.24
36
142
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
42
4.59
8.14
1.3
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
14
24
5.90
7.86
1.7
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
253
2.32
7.85
1.3
2.7
g/l
10.7
10.5
0.07
51
225
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
144
2.77
7.84
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
105
588
1.87
7.80
3.0
2.5
e9/l
3.8
4.1
0.70
85
464
(3007853) Bacteria identified in Skin by Aerobe culture
163
1040
1.67
7.73
2.1
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
91
488
1.95
7.70
3.6
3.4
pmol/l
4.3
4.6
2.38
85
426
(3024932) HLA-DR beta [Type]
16
32
5.06
7.68
1.6
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
985
9193
1.91
7.59
20.1
9.8
u/l
27.9
27.7
0.18
971
8883
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
12
8.40
7.59
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
89
479
1.94
7.46
2.1
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
16
33
4.91
7.42
1.1
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
59
3.79
7.38
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
41
161
2.61
7.33
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
23
64
3.65
7.33
2.3
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
46
4.19
7.29
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
30
100
3.06
7.24
1.2
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
276
2.20
7.19
1.3
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
276
2.20
7.19
1.3
2.7
g/l
7.5
7.3
0.33
47
219
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
276
2.20
7.19
1.3
2.7
g/l
3.8
3.7
0.08
46
209
(3035880) pH of Pleural fluid
17
38
4.53
7.19
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
16
34
4.76
7.18
1.5
2.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
13
7.76
7.13
2.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
13
7.76
7.13
2.1
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
13
7.76
7.13
2.1
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
175
1163
1.60
7.03
1.4
1.3
titre
314.4
484.6
2.02
36
225
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
130
2.75
6.98
1.3
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
31
108
2.93
6.94
3.0
2.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
28
92
3.10
6.93
4.2
3.0
%
48.6
54.1
0.45
18
66
(3013512) EKG study
304
2287
1.46
6.84
5.0
3.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
165
1101
1.59
6.50
1.4
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
858
7811
1.50
6.37
6.2
4.5
mu/l
2.1
2.2
0.05
815
7185
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
15
6.72
6.32
1.6
4.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
21
61
3.49
6.31
5.6
3.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
88
504
1.81
6.11
4.2
3.6
mmol/l
2.4
1.6
1.07
67
371
(3052851) Hemolysis interference index of Serum or Plasma
51
241
2.17
6.10
4.3
3.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
138
897
1.62
6.05
9.6
8.4
mmol/l
1.4
1.1
0.48
109
708
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
262
2.12
6.05
1.3
2.7
g/l
3.4
3.1
1.17
46
214
(3006922) Hepatitis E virus Ab [Presence] in Serum
20
58
3.49
6.03
1.1
1.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
138
898
1.62
6.02
9.7
8.3
kpa
5.0
5.1
0.35
133
860
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
66
346
1.97
6.00
1.3
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
138
899
1.61
6.00
9.6
8.3
kpa
11.3
12.4
2.22
133
863
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
65
3.28
5.74
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
33
132
2.55
5.74
3.4
2.5
—
—
—
0
0
(3009343) pH of Capillary blood
90
531
1.76
5.67
4.2
3.6
ph
7.4
7.4
1.97
15
64
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
159
2.37
5.54
1.2
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
64
344
1.92
5.43
2.9
1.9
—
—
—
0
0
(3019225) pH of Specimen
121
782
1.62
5.43
5.3
4.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
35
149
2.39
5.36
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
664
5852
1.36
5.36
5.0
4.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
23
79
2.95
5.32
5.4
3.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
79
2.95
5.32
1.1
1.2
u/l
57.4
51.8
0.19
18
54
(3001122) Ferritin [Mass/volume] in Serum or Plasma
465
3890
1.35
5.28
3.5
2.8
ug/l
267.2
121.1
6.07
447
3615
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
89
538
1.71
5.16
4.3
3.5
kpa
5.1
5.1
0.11
84
502
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
50
252
2.03
5.11
1.4
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
50
252
2.03
5.11
1.3
1.2
titre
114.2
84.2
0.52
12
26
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
32
134
2.43
5.09
1.1
1.2
u/l
81.9
35.9
0.68
26
116
(40761536) Microorganisms panel - Urine sediment
112
724
1.61
5.03
4.4
3.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
50
254
2.02
5.00
1.4
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
82
2.84
5.00
2.5
2.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
62
342
1.86
4.89
1.3
1.4
miu/ml
142.0
236.4
1.25
18
163
(42529406) Shigella sp [Presence] in Stool by Culture
50
257
1.99
4.85
1.4
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
52
3.31
4.76
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
52
3.31
4.76
1.1
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
21
74
2.87
4.67
6.3
4.6
u/ml
76.3
47.5
—
10
22
(3019309) Folate [Moles/volume] in Red Blood Cells
190
1397
1.44
4.66
1.7
1.7
nmol/l
1130.4
1169.0
0.27
162
1075
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
89
556
1.66
4.59
3.7
4.1
ng/l
88.4
83.1
0.21
74
498
(3020891) Body temperature
56
306
1.88
4.56
5.3
4.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
21
4.80
4.54
2.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
15
44
3.44
4.47
1.1
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
19
65
2.96
4.46
1.2
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
28
120
2.37
4.27
1.2
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
240
1866
1.37
4.23
1.6
1.5
nmol/l
19.1
20.6
0.86
215
1596
(21494434) Karyotype in Bone marrow
21
80
2.66
4.08
1.1
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
117
803
1.51
4.06
3.1
2.5
u/l
38.5
32.5
0.58
100
690
(3026008) Bacteria identified in Urine by Culture
288
2316
1.33
4.06
3.3
2.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
302
2447
1.33
4.04
2.1
2.1
u/l
163.9
274.3
1.74
292
2310
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
28
3.96
3.98
3.4
4.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
43
3.29
3.91
1.1
1.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
8
11
7.32
3.86
4.3
6.6
umol/l
0.2
0.3
—
8
11
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
54
310
1.78
3.80
2.4
3.6
u/ml
375.3
4500.8
0.70
42
267
(3019832) Treponema pallidum Ab [Presence] in Serum
158
1170
1.41
3.71
1.5
1.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
16
5.66
3.66
1.1
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
20
79
2.56
3.64
1.6
2.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
51
2.97
3.58
1.1
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
98
667
1.52
3.56
2.2
2.3
ug/l
6.8
7.7
0.28
88
600
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
54
318
1.74
3.51
2.0
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
672
6108
1.27
3.46
3.5
3.3
—
—
—
0
0
(4094501)
38
202
1.91
3.43
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
94
2.37
3.42
1.1
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
50
291
1.75
3.39
2.2
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
14
5.75
3.34
1.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
67
427
1.61
3.26
2.8
2.8
e6/l
0.4
0.2
1.04
67
417
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
43
3.05
3.25
1.4
1.6
—
1224630.0
—
0
5
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
202
0.29
3.24
1.2
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
77
509
1.55
3.21
6.7
5.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
376
3219
1.26
3.15
1.9
1.9
pmol/l
90.7
95.2
1.35
210
1723
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
105
2.22
3.11
2.4
2.5
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
6
8
7.53
3.05
1.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
8
7.53
3.05
1.0
5.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
23
106
2.20
3.04
2.4
2.5
mmol/l
105.7
105.1
0.22
23
106
(3041354) Potassium [Moles/volume] in Venous blood
23
106
2.20
3.04
2.4
2.5
mmol/l
4.3
4.1
0.96
23
106
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
42
241
1.77
3.02
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
36
197
1.86
3.01
1.6
1.3
e6/l
4.8
25.1
0.70
28
157
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
36
197
1.86
3.01
1.6
1.4
e6/l
5.3
703.9
0.69
29
161
(3001019) Free T4 and TSH panel - Serum or Plasma
70
461
1.55
2.98
1.7
1.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
15
57
2.65
2.97
2.3
3.0
u/ml
156.6
45.3
0.37
15
57
(3004716) Salmonella sp identified in Stool by Organism specific culture
75
503
1.53
2.95
1.4
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
91
636
1.47
2.94
2.5
2.5
ml/min/173m2
66.1
70.3
0.44
37
253
(3022313) Gas panel - Capillary blood
61
396
1.57
2.78
4.2
3.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
31
3.25
2.77
2.3
2.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
27
138
1.98
2.77
1.8
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
26
132
1.99
2.72
1.8
3.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
86
606
1.46
2.68
1.2
1.2
iu/ml
93.3
138.5
0.49
19
245
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
41
243
1.71
2.67
1.2
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
11
5.48
2.54
1.2
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
136
1.93
2.52
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
42
255
1.67
2.52
1.3
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
130
1.95
2.47
1.1
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
12
5.02
2.40
1.5
2.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
65
445
1.49
2.37
2.2
2.4
u/l
4166.9
4932.7
0.12
22
185
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
17
4.14
2.36
8.4
5.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
17
4.14
2.36
1.3
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
36
214
1.71
2.35
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
275
0.43
2.33
1.5
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
28
3.23
2.31
2.2
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
643
5948
1.20
2.29
3.8
3.2
u/l
56.8
48.2
1.75
609
5591
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
47
302
1.58
2.28
1.7
1.6
iu/ml
1.0
0.1
0.56
13
54
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
53
2.47
2.28
1.4
1.6
u/l
11.7
6.2
—
6
27
(3024928) Oxygen saturation in Venous blood
31
179
1.75
2.24
5.0
3.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
9
5.57
2.21
1.8
2.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
28
158
1.79
2.19
1.5
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
67
2.26
2.18
1.7
1.6
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
6
14
4.30
2.15
6.0
1.5
—
211.6
—
0
7
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
37
2.72
2.10
2.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
37
2.72
2.10
2.3
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
30
176
1.72
2.07
1.5
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
15
4.02
2.04
1.5
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
15
4.02
2.04
1.2
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
26
3.09
2.01
1.0
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
223
1887
1.23
1.99
1.6
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
459
4161
1.18
1.94
4.2
3.3
estimate
0.0
0.0
0.00
109
790
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
11
4.56
1.94
1.6
2.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
11
4.56
1.94
1.8
2.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
29
173
1.70
1.91
1.4
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
458
4158
1.18
1.89
5.8
4.6
estimate
0.0
0.0
0.50
111
813
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
120
1498
0.78
1.88
2.1
2.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
29
174
1.69
1.87
1.4
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
103
800
1.32
1.86
2.4
2.3
nmol/l
12.3
13.2
0.64
98
720
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
108
1364
0.77
1.85
1.9
2.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
17
3.54
1.84
2.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
80
2.02
1.80
1.8
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
23
3.06
1.80
1.3
1.1
%
105.7
100.4
—
7
23
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
23
3.06
1.80
1.3
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
13
60
2.18
1.78
1.2
1.0
u/l
1.3
1.1
—
6
31
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
41
2.45
1.75
2.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
41
2.45
1.75
2.4
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
120
962
1.28
1.72
22.8
23.1
inr
1.2
1.3
0.54
20
143
(3037121) Protein [Mass/volume] in Urine
46
317
1.47
1.69
2.6
3.4
g/l
0.9
0.3
0.72
21
140
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
19
104
1.84
1.68
1.1
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
31
197
1.59
1.64
3.1
3.6
umol/l
40.3
35.6
0.47
24
165
(3024869) Neuronal Ab [Presence] in Serum
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
14
3.58
1.61
1.0
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
824
8555
0.84
1.61
4.5
4.5
mmol/l
2.7
2.8
0.75
766
7929
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
70
2.01
1.59
1.6
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
59
433
1.38
1.56
14.2
11.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
240
2094
1.19
1.55
1.3
1.3
u/ml
0.7
1.6
2.35
57
579
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
116
940
1.26
1.54
10.4
6.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
71
1.98
1.54
1.6
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
193
1.57
1.52
2.4
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
51
2.17
1.51
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
217
1884
1.19
1.48
4.1
3.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
17
94
1.82
1.48
5.0
8.5
mmol/l
6.6
7.1
0.39
12
78
(40761511) CBC panel - Blood by Automated count
938
9118
1.23
1.47
22.7
12.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
29
187
1.57
1.47
1.3
1.1
u/ml
23.8
25.7
—
6
13
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
40
278
1.46
1.44
2.0
2.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
5
16
3.13
1.44
1.0
1.1
—
92.6
—
0
5
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
51
373
1.39
1.40
1.0
1.1
u/ml
—
1.0
—
0
5
(3005082) Progesterone [Moles/volume] in Serum or Plasma
10
46
2.18
1.40
1.6
1.2
nmol/l
32.4
30.8
—
10
38
(3008295) Osmolality of Serum or Plasma
16
89
1.81
1.37
1.1
1.6
mosm/kgh2o
280.4
281.9
—
9
66
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
851
8212
1.18
1.37
4.7
4.2
mmol/l
5.9
5.9
0.09
791
7520
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
41
2.21
1.37
1.1
1.0
miu/ml
490.6
1578.0
—
9
41
(3032057) Clostridioides difficile [Presence] in Stool
5
17
2.95
1.36
1.8
1.9
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
17
2.95
1.36
1.0
1.1
—
77.2
—
0
5
(3000330) Specific gravity of Urine by Test strip
52
384
1.37
1.36
4.6
3.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
810
8389
0.86
1.35
4.0
4.1
mmol/l
1.4
1.4
2.82
756
7789
(3009542) Hematocrit [Volume Fraction] of Blood
846
8164
1.17
1.34
29.2
13.9
%
39.3
40.3
3.26
633
6187
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
9
42
2.15
1.34
1.1
1.1
u/l
126.2
80.2
—
9
32
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
9
42
2.15
1.34
1.1
1.1
u/l
55.7
25.5
—
9
31
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
34
233
1.47
1.33
1.2
1.2
u/ml
5.2
6.0
—
5
34
(3009261) Glucose [Presence] in Urine by Test strip
455
4213
1.14
1.32
4.3
3.4
estimate
0.0
0.0
0.00
108
772
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
30
201
1.51
1.31
1.5
1.8
iu/l
1.5
6.3
—
10
61
(1002224) Polysomnography panel
26
386
0.67
1.25
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
240
0.58
1.24
2.1
1.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
56
1.97
1.22
1.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
15
251
0.59
1.21
1.7
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
28
189
1.49
1.19
5.0
3.9
mg/l
28.7
23.9
0.41
19
123
(3022145) Colonoscopy Study observation
113
945
1.22
1.17
1.4
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
87
1.73
1.15
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
20
2.51
1.15
7.8
7.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
208
1.46
1.14
5.1
4.5
—
—
—
0
0
(4281824)
12
65
1.86
1.13
1.3
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
119
1.61
1.12
2.2
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
40
294
1.37
1.11
2.7
2.3
ug/l
483.2
437.0
0.06
34
275
(4027681)
12
66
1.83
1.09
1.3
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
41
1.96
1.09
1.0
1.2
nmol/l
130.4
148.6
—
8
41
(21494755) Public health laboratory ask at order entry panel
82
994
0.81
1.05
1.2
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
82
1.72
1.05
1.5
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
15
90
1.68
1.04
1.4
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
83
1.70
1.01
1.4
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
134
0.52
0.99
9.4
5.8
umol/l
398.9
370.3
—
7
118
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
29
0.00
0.98
0.0
1.3
—
8.8
—
0
29
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
54
1.86
0.96
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
50
1.81
0.96
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
225
1.39
0.95
1.6
1.4
ug/g
260.8
300.4
0.56
21
127
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
739
7642
0.89
0.95
5.6
5.4
mmol/mol
40.2
39.4
1.25
691
7119
(3029937) Albumin [Presence] in Urine by Test strip
245
2224
1.13
0.94
4.8
3.6
estimate
0.0
0.0
1.08
106
780
(40768446) Kidney Pathology biopsy report
7
37
1.90
0.94
2.0
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
55
1.83
0.92
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
28
2.15
0.91
1.2
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
86
1.64
0.91
3.4
3.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
29
2.07
0.89
1.5
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
29
2.07
0.89
1.5
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
42
1.91
0.88
1.3
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
64
1.73
0.86
5.5
3.9
%
12.3
10.9
0.86
11
64
(3020717) Zinc [Moles/volume] in Serum or Plasma
8
45
1.78
0.84
1.1
1.2
umol/l
10.4
24.2
—
8
40
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
45
1.78
0.84
1.5
2.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
45
1.78
0.84
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
29
387
0.74
0.83
1.2
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
32
1.88
0.82
1.7
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
32
1.88
0.82
2.7
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
54
662
0.81
0.81
1.6
1.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
58
1.73
0.79
1.6
1.4
g/l
1.0
1.0
—
10
58
(3044242) Glucose [Moles/volume] in Arterial blood
8
48
1.67
0.79
2.3
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
182
1642
1.13
0.78
1.7
1.6
pmol/l
420.8
21475477.7
1.52
158
1383
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
74
1.63
0.78
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
90
1.56
0.78
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
990
9762
1.19
0.78
42.8
19.2
e9/l
249.8
249.5
0.04
974
9516
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
49
600
0.81
0.74
1.2
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
223
2424
0.90
0.73
3.8
4.2
%
21.3
21.2
0.03
115
1101
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
39
1.80
0.72
1.6
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
60
1.67
0.72
1.2
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
84
1.55
0.72
1.5
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
68
1.62
0.72
1.7
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
49
597
0.81
0.71
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
252
0.71
0.71
1.7
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
57
1.58
0.71
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
825
8437
0.90
0.71
4.1
4.1
mmol/l
4.6
4.6
0.73
777
7872
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
354
0.76
0.71
1.7
1.9
—
—
—
0
0
(3024731) MCV [Entitic volume]
990
9771
1.18
0.71
42.6
19.1
fl
90.4
90.6
0.57
983
9639
(3020650) Glucose [Presence] in Urine
5
26
1.93
0.70
1.2
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
990
9772
1.18
0.70
42.5
19.1
pg
30.0
30.3
4.39
983
9639
(3026361) Erythrocytes [#/volume] in Blood
990
9773
1.18
0.69
42.7
19.2
e12/l
4.4
4.6
16.71
974
9511
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
419
0.78
0.69
1.2
2.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
42
1.67
0.68
3.3
3.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
990
9775
1.17
0.68
42.7
19.2
e9/l
6.6
6.8
0.77
972
9505
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
27
205
1.33
0.67
2.6
2.4
ug/min
179.4
118.7
0.25
16
123
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
43
1.63
0.67
1.1
1.1
—
13.2
—
0
5
(3000963) Hemoglobin [Mass/volume] in Blood
990
9777
1.17
0.66
43.0
19.3
g/l
130.5
137.0
30.17
983
9644
(3042733) HLA Ab [Presence] in Serum
5
28
1.79
0.66
5.8
4.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
205
2226
0.90
0.66
1.8
1.7
mmol/l
1.5
1.4
0.54
180
1885
(3049717) Cytology report of Urine Cyto stain
40
322
1.25
0.66
3.0
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
44
536
0.81
0.65
1.3
2.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
62
1.62
0.65
3.0
2.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
10
152
0.65
0.61
1.4
1.1
u/ml
1.7
3.4
—
5
44
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
77
884
0.86
0.61
1.6
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
88
1.48
0.60
1.4
1.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
2.0
—
16.7
—
0
20
(3016879) Cocaine [Presence] in Urine
41
496
0.82
0.58
1.2
2.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
150
0.66
0.58
1.1
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
252
2355
1.09
0.58
3.9
3.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
75
655
1.16
0.55
4.2
3.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
37
1.63
0.55
1.0
2.7
ug/l
18.9
246.6
—
6
31
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
15
107
1.41
0.55
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
38
1.58
0.54
1.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
60
1.50
0.54
2.8
2.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
371
0.80
0.53
1.3
1.8
mg/l
5.1
2.9
1.26
23
252
(3027008) Opiates [Presence] in Urine
45
533
0.84
0.53
1.3
2.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
13
91
1.43
0.53
1.6
2.0
nmol/l
17.8
21.5
0.81
13
84
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
72
820
0.87
0.53
1.9
2.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
20
152
1.32
0.52
1.0
1.1
—
12.8
—
0
11
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
180
0.72
0.51
1.4
1.1
u/ml
0.7
2.3
—
6
81
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
41
1.47
0.50
1.8
2.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
45
529
0.84
0.50
1.3
2.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
42
355
1.19
0.47
1.7
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
338
3226
1.07
0.46
4.6
3.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
91
1006
0.90
0.44
3.9
4.2
%
31.4
31.3
0.03
67
699
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
139
1.30
0.44
1.3
1.2
u/ml
2.4
4.1
—
8
59
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
104
1.35
0.43
1.1
1.1
—
—
—
0
0
(4146454)
6
91
0.66
0.42
2.8
2.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
12
87
1.38
0.42
1.7
2.3
mg/l
23.7
23.6
—
6
24
(40768800) Prostate Pathology biopsy report
23
185
1.25
0.42
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
19
149
1.28
0.42
1.9
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
175
1868
0.92
0.41
4.6
3.6
kg/l
1.0
1.0
0.45
23
260
(3000285) Sodium [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
161
0.74
0.41
1.2
1.1
u/ml
19.5
6.1
—
7
92
(3001556) Androgen free Index in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
114
1.32
0.41
3.7
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
17
0.00
0.40
0.0
2.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
17
0.00
0.40
0.0
1.9
—
8.1
—
0
8
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
150
1.27
0.40
1.7
1.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
0.2
—
0
5
(3000764) Benzodiazepines [Presence] in Urine
46
527
0.87
0.39
1.3
2.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
115
1.31
0.39
3.7
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
115
1.31
0.39
3.7
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
133
1431
0.92
0.38
1.2
1.3
iu/ml
43.5
31.4
0.33
35
442
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
80
1.38
0.38
1.0
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
124
1149
1.09
0.37
2.1
2.5
ug/g
136.9
120.1
0.28
105
912
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
116
1.30
0.37
3.7
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
116
1.30
0.37
3.7
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
116
1.30
0.37
3.7
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
47
532
0.88
0.35
2.5
2.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
291
3033
0.94
0.35
4.1
4.7
ug/l
2.0
2.4
0.66
260
2724
(3020876) Protein [Mass/time] in 24 hour Urine
10
73
1.37
0.34
1.4
2.4
—
1.0
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
31
265
1.17
0.34
1.9
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
155
0.77
0.33
1.3
1.1
u/ml
0.7
2.2
—
6
75
(3024263) Appearance of Synovial fluid
6
46
1.31
0.33
2.0
1.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
46
1.31
0.33
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
60
541
1.12
0.32
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
168
1774
0.94
0.31
2.8
3.0
ug/l
0.7
0.7
0.06
113
1119
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
97
0.72
0.31
1.1
1.3
nmol/l
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
54
1.30
0.30
2.1
1.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
84
1.31
0.30
5.0
3.1
nmol/l
3.5
5.3
0.38
11
84
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
108
0.74
0.29
1.3
1.4
nmol/l
0.6
0.6
—
8
100
(3014051) Protein [Presence] in Urine by Test strip
21
176
1.20
0.29
1.8
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
128
1359
0.93
0.28
1.2
1.2
u/ml
7.4
12.2
0.34
38
532
(44813793)
8
63
1.27
0.27
1.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
8
65
1.23
0.27
1.4
1.1
nmol/l
370.9
409.2
—
8
56
(3020682) Albumin/Creatinine [Ratio] in Urine
249
2397
1.05
0.27
4.4
4.1
mg/mmol
8.5
9.9
0.28
172
1562
(3008898) HLA-B27 [Presence]
32
363
0.88
0.26
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
236
2270
1.05
0.26
3.5
3.4
mg/l
260.3
232.9
0.05
163
1508
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
72
1.25
0.25
3.3
2.5
—
—
—
0
0
(4034850)
22
256
0.86
0.25
14.5
10.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
217
1.16
0.24
1.4
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
92
0.76
0.22
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
157
0.83
0.22
1.6
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
312
3206
0.96
0.22
2.8
2.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
124
0.80
0.21
3.3
2.0
%
13.6
13.1
—
10
124
(36660697) Celiac disease serology panel - Serum
68
729
0.93
0.21
1.1
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
38.0
—
0
10
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
43
1.16
0.21
3.0
2.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
13
0.00
0.21
0.0
5.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.8
—
63.6
—
0
13
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
62.2
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
30
269
1.12
0.20
1.3
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
50
1.20
0.19
1.0
1.4
—
20.7
—
0
10
(3028707) Methadone [Presence] in Urine by Screen method
21
239
0.88
0.19
1.2
2.8
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
11
90
1.22
0.19
1.3
1.5
mmol/l
11.2
13.1
—
6
19
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
40
366
1.10
0.19
2.3
2.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
30
270
1.11
0.19
1.3
1.4
—
—
—
0
0
(4198724)
6
53
1.13
0.18
1.2
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
800
8071
0.97
0.18
3.9
3.7
mmol/l
1.3
1.3
0.69
749
7476
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
12
100
1.20
0.18
1.4
1.1
%
82.2
95.3
0.68
12
94
(4010399)
52
558
0.93
0.17
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
138
1.16
0.17
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
131
0.84
0.17
1.4
1.5
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
5
67
0.75
0.17
1.2
1.1
—
72.0
—
0
5
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
67
0.75
0.17
1.2
1.1
—
61.9
—
0
8
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
53
496
1.07
0.16
1.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
131
1261
1.04
0.16
1.6
1.8
%
1.4
1.5
0.50
118
1117
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
140
1.15
0.15
1.0
1.1
u/ml
1.7
2.7
—
9
62
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
140
1.15
0.15
1.3
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
263
2571
1.03
0.15
3.3
3.3
mmol/l
7.8
8.2
0.67
218
2165
(3043238) Trisomy 21 risk [Likelihood] in Fetus
30
276
1.09
0.13
1.4
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
100
0.80
0.13
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
315
0.92
0.13
1.7
1.6
—
—
—
0
0
(4268621)
11
94
1.17
0.13
2.1
2.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
46
1.09
0.09
1.0
1.3
—
70.0
—
0
5
(3025577) Chromium [Mass/volume] in Blood
5
46
1.09
0.09
2.4
2.2
ug/l
2.7
1.9
—
5
37
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
46
1.09
0.09
1.2
1.1
iu/ml
343.8
225.1
—
5
46
(3026470) Cobalt [Mass/volume] in Blood
5
46
1.09
0.09
1.6
2.2
ug/l
2.9
3.5
—
5
40
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
134
1307
1.03
0.09
1.5
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
5
48
1.04
0.09
1.0
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
55
1.09
0.09
1.0
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
36
341
1.06
0.08
1.5
1.8
nmol/l
42.8
38.1
0.72
36
326
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
5
65
0.77
0.08
1.2
1.1
—
43.2
—
0
5
(3039443) Prostate specific Ag panel - Serum or Plasma
22
205
1.07
0.08
1.6
1.6
—
—
—
0
0
(4024509)
6
70
0.86
0.07
2.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
225
1.07
0.07
2.2
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
86
1.05
0.07
1.2
1.0
mg/l
331.8
284.0
—
9
76
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
173
0.92
0.06
1.6
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
101
0.89
0.06
1.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
35
364
0.96
0.05
1.5
3.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
34
327
1.04
0.05
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
34
327
1.04
0.05
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
34
328
1.04
0.04
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
34
328
1.04
0.04
1.3
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
129
0.93
0.03
1.2
1.1
u/ml
7.3
4.0
—
6
53
(3044941) Cell count panel - Synovial fluid
12
128
0.94
0.02
1.9
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
107
1080
0.99
0.02
1.6
1.5
—
—
—
0
0
(4306422)
14
133
1.05
0.01
1.4
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
104
1031
1.01
0.01
2.0
1.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
144
0.97
0.00
1.1
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
15
146
1.03
0.00
2.5
2.5
umol/l
6.5
5.1
—
10
104
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
25
249
1.00
0.00
1.8
1.9
pmol/l
203.0
215.5
0.17
25
235
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
26
261
1.00
0.00
1.0
1.1
u/ml
4.0
6.9
—
7
33
(3027456) Digoxin [Moles/volume] in Serum or Plasma
14
135
1.04
0.00
3.5
3.0
nmol/l
0.7
0.9
—
9
105
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
115
0.96
0.00
1.2
1.1
u/ml
5.3
6.4
—
5
52
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
36
360
1.00
0.00
1.3
1.5
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
10.4
—
0
8
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
5.9
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
178.8
—
0
6
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1.5
—
0
5
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.0
—
412.8
—
0
5
(3025315) Body weight
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
100.7
—
0
7
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
9.7
—
0
6
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
69
1.01
0.00
1.7
1.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
342.7
—
0
6
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
49
1.02
0.00
3.4
2.5
umol/l
70.0
49.1
—
5
41
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_HODGKIN_LYMPHOMA – Hodgkin lymphoma, hilmo
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).